Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
With ongoing research, new formulations, and combination therapies on the horizon, patients can expect even more innovative options for managing their diabetes
Always consult an oncologist
No therapeutic or clinical claims are made or implied
Across GLP-1 subtypes, we observe that much of the increase in prescriptions is driven by semaglutide and tirzepatide, which aligns with the dates of their FDA approvals (Charts 3 and 4)
US$ 27.35
US$ 24.93
US$ 27.60
US$ 22.99
